Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
Tue news: Novo looks to speed up India Wegovy launch. 4 revelations from MN’s 340B transparency report. 4 oral GLP-1R’s in dev. Roche autoimmune partnership. Gilead-Tubulis alliance. See more on our front page
Abbvie we know you have to post new job listing for 5 days. You pull post because you filled with internal after people applied. Even worse is your recruiters line up 1-2 sacrificial external candidates who don’t have a chance in hell but you put them through several rounds knowing current...
I'm a writer working on a story for publication re: the impact of IQVIA (and similar) data on healthcare. Did INSYS use prescription data to allocate kickbacks based on prescription volume of certain docs? You can reach me at: medwriter963@gmail.com. Thank you.
anonymous
Thread
drug rep
drug reps
insys
iqvia
pharmaceuticalcompany
I am a medical writer looking for someone willing to go on the record regarding violations of PDRP (physician data restriction program) by drug manufacturers. That is, I'm interested knowing about prescription info of PDRP doctors being made available to drug reps.
I look forward to hearing...
What do startups and modern pharma companies have in common? There are two factors mentioned in article Embracing the Start-up Mindset in Pharma :
the increasing trend [...] to pay a value-based price for value actually delivered and not just for the physical product itself
the increasing...
anonymous
Thread
b2b
business
business growth
business strategy
leadership
pharma
pharmaceuticalcompany
startup
value proposition
Arrowhead Pharmaceuticals reports a loss of $0.12 per share in Q4 2018. Arrowhead doesn't report Q4 numbers in the quarterly press release. They only report Q4 numbers in the SEC filing.
anonymous
Thread
arrowhead
arrowhead pharma
arrowhead pharmaceuticals
earnings
hepatatis b
janssen
johnson&johnson
loss
pharmaceuticalcompany
The latest pharma giant to bow to Trump’s pressure on drug price is Merck (MRK). The company announced on Thursday that it would lower price on at least six of its drug in the US by 10% or more.
https://news.alphastreet.com/merck-joins-pharma-giants-in-lowering-drug-prices/
Pfizer (PFE) is an interesting stock to follow. Apart from being a great dividend stock, the company also boasts of a diversified portfolio, strong free cash flow, and consistency in beating earnings expectations. Let’s quickly take a look at the pros and cons...
Upping its ante against its rivals in the medical and pharma sector, Walgreens has finally completed its acquisition of Rite Aid’s stores for $4.4billion. The deal brings 1,932 Rite Aid stores as well as three distribution centers under the umbrella of Walgreens.
Though Walgreens initially...
anonymous
Thread
drug
medical sales
pharmaceuticalcompany
walgreens
Johnson & Johnson may not be having a great 2018 so far with the stock ticking down about 8% since the year started. But is it time to get rid of the world’s largest pharma company’s shares? Let’s see.
anonymous
Thread
drug
johnson&johnson
pharma
pharmaceuticalcompany
stocks
Privately-held Albertsons Companies is planning to buy the portion of Rite Aid that is not being sold to Walgreens Boots Alliance.
The combined value of Albertsons and Rite Aid, including debt, is around $24 billion. The proposed cash-and-stock deal will give Albertsons shareholders ownership...
Hello, my colleagues and I at Columbia University are collecting data on cancer clinical trials to better understand the needs of the healthcare community. Please respond to the below questions and thank you in advance for taking the time to complete this questionnaire...